Evolution of the functional profile of HIV-specific CD8 + T cells in patients with different progression of HIV infection over 4 years

Journal of Acquired Immune Deficiency Syndromes

Volumn 55, Issue 1, 2010, Pages 29-38

  Peris Pertusa, Alejandra ^a   López, Mariola ^a   Rallón, Norma I ^a   Restrepo, Clara ^a   Soriano, Vincent ^a   Benito, Jose M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Antiretroviral therapy; CD8 + T cells; Elite controllers; HIV; Immune responses

Indexed keywords

GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NEF PROTEIN; TUMOR NECROSIS FACTOR ALPHA; CCL4 PROTEIN, HUMAN;

ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; VIRUS REPLICATION; BIOSYNTHESIS; IMMUNOLOGY; LONGITUDINAL STUDY; T LYMPHOCYTE SUBPOPULATION;

CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL4; DISEASE PROGRESSION; FLOW CYTOMETRY; GENE PRODUCTS, GAG; HIV INFECTIONS; HUMANS; INTERLEUKIN-2; LONGITUDINAL STUDIES; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956626741     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181e69609     Document Type: Article

References (32)

1. + lymphocytes. Science. 1999;283:857-860.
2. Jin X, Bauer D, Tuttleton S, et al. Dramatic rise in plasma viremia after CD8 (+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med. 1999;189:991-998. (Pubitemid 29149355)
3. + cytotoxic T-lymphocyte activity associated with control of viremia in primary HIV type 1 infection. J Virol. 1994;68:6103-6110. (Pubitemid 24258634)
4. Koup R, Safrit J, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary HIV type 1 syndrome. J Virol. 1994;68:4650-4655. (Pubitemid 24183063)
5. Pontesilli O, Klein M, Kerkhof-Garde S, et al. Longitudinal analysis of HIV type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with non-progressive infection. J Infect Dis. 1998;178:1008-1018. (Pubitemid 28452192)
6. Cao Y, Qin L, Zhang L, et al. Virologic and immunologic characterization of long-term survivors of HIV type 1 infection. N Engl J Med. 1995;332:201-208.
7. Lambotte O, Boufassa F, Madec Y, et al. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis. 2005;41:1053-1056. (Pubitemid 41368233)
8. Carmichael A, Jin X, Sissons P, et al. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med. 1993;177:249-256. (Pubitemid 23117074)
9. Saksena N, Rodes B, Wang B, et al. Elite HIV controllers: myth or reality? AIDS Rev. 2007;9:195-207. (Pubitemid 351181618)
10. Saez-Cirion A, Pancino G, Sinet M, et al. HIV controllers: how do they tame the virus? Trends Immunol. 2007;28:532-540.
11. Deeks S, Walker B. HIV controllers: mechanisms of durable virus control in the absence of ARV therapy. Immunity. 2007;27:416.
12. + T cells in HIV-infected progressors and long-term nonprogressors. J Immunol. 2000;165:1082-1092. (Pubitemid 30484780)
13. Pereyra F, Addo MM, Kaufmann DE, et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis. 2008;197:563-571. (Pubitemid 351321534)
14. + T cells. Blood. 2006;107:4781-4789. (Pubitemid 43882629)
15. *5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA. 2000;97:2709-2714. (Pubitemid 30159236)
16. Zimmerli S, Harari A, Cellerai C, et al. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci USA. 2005;102:7239-7244. (Pubitemid 40696363)
17. Rowland-Jones S, Pinheiro S, Kaul R, et al. How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection? Immunol Lett. 2001;79:15-20. (Pubitemid 32938203)
18. + T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med. 2007;204:2473-2485. (Pubitemid 47529331)
19. Rodes B, Toro C, Paxinos E, et al. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection. AIDS. 2004;18:1109-1116. (Pubitemid 38738510)
20. Lopez M, Soriano V Rallon N, et al. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8 (+) T cells. Eur J Immunol. 2008;38:1548-1558.
21. + responses between long-term nonprogressors and typical progressors. AIDS Res Hum Retroviruses. 2008;24:1185-1195.
22. + T cells. PLoS Med. 2008;5:e100.
23. + T cells is required for HIV-infected cell elimination associated with immune control. Immunity. 2008;29:1009-1021.
24. + T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med. 2007;13:43-53.
25. Appay V Nixon D, Donahoe S, et al. HIV-specific CD8 (+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med. 2000;192:63-75. (Pubitemid 30470807)
26. Zajac A, Blattman J, Murali-Krishna K, et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med. 1998;188:2205-2213. (Pubitemid 29028493)
27. + T-cell responses to the gag protein of HIV type 1 correlates inversely with viral load in plasma. J Virol. 2002;76:2298-2305. (Pubitemid 34150698)
28. Ndongala M, Peretz Y, Boulet S, et al. HIV Gag p24 specific responses secreting IFN-gamma and/or IL-2 in treatment-naive individuals in acute infection early disease are associated with low viral load. Clin Immunol. 2009;131:277-287.
29. Harari A, Dutoit V, Cellerai C, et al. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev. 2006;211:236-254. (Pubitemid 43882976)
30. Wherry E, Blattman J, Murali-Krishna K, et al. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol. 2003;77:4911-4927. (Pubitemid 36402840)
31. + T cell responses. Curr Mol Med. 2007;7:446-458. (Pubitemid 47244890)
32. + T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J Virol. 2008;82:3391-3404. (Pubitemid 351429916)